App-Quantinova.ai

NEUROPSYCHIATRIC MANIFESTATIONS IN PEDIATRIC-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: EXPERIENCE OF A SPANISH TERTIARY CENTER

W.A. Sifuentes Giraldo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

RISK FACTORS OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH RHEUMATHOID ARTHRITIS (RA)

M.A. Satybaldyeva - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Glucocorticoid

OVEREXPRESSION OF UPAR IN FIBROBLAST-LIKE SYNOVIOCYTES PROMOTES ANGIOGENESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS

L. Yan - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

A. Rybnikov - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Pradax

ASSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES AND ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS

K.J. Kim - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

CLINICAL ANALYSIS OF PREOPERATIVE DEEP VEIN THROMBOSIS RISK FACTORS IN PATIENTS UNDERGOING PRIMARY TOTAL KNEE ARTHROPLASTY

H. Wakabayashi - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?

Jonas K Eriksson - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Is Hyperuricemia An Independent Risk Factor for Arterial Thrombosis in Systemic Lupus Erythematosus?

C.C. Mok - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Neurological Involvement in Patients with Antiphospholipid Syndrome: A Case Series with A Long-Term Follow-Up

M. Estevez - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Asymptomatic Deep Vein Thrombosis in Anca-Associated Vasculitides

E. Makarov - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Is Hyperuricemia An Independent Risk Factor for Arterial Thrombosis in Systemic Lupus Erythematosus?

C.C. Mok - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Neurological Involvement in Patients with Antiphospholipid Syndrome: A Case Series with A Long-Term Follow-Up

M. Estevez - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Asymptomatic Deep Vein Thrombosis in Anca-Associated Vasculitides

E. Makarov - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Selective Factor Xa Inhibitors in Treatment and Prevention of Thromboses in Patients with Rheumatic Diseases

N. Seredavkina - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

rivaroxaban

Post-Processing Techniques for Enhanced Visualization of Pulmonary Vasculitis and Pulmonary Thrombosis by Multislice Spiral Computed Tomography in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

I. Leineman - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Occurrence of Vascular Access Thrombosis in Patients with Systemic Lupus Erythematosus on Hemodialysis

N.O. El-Azizi - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Red Cell Complement Loading In PNH Patients On Eculizumab Is Associated With a C3 Polymorphism Which Influences C3 Function, Predicts For Increased Extravascular Hemolysis and Provides a Rationale For C3 Inhibition.

Praveen Kaudlay - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Eculizumab

Management Of Pregnancy In Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report Of 10 Cases From The Working Group On Pregnancy Of The Japan PNH Study Group

Kensuke Usuki - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Eculizumab

The Transcripts Of Platelet-Endothelial Adhesion Molecules and Inflamatory Chemokine Activation Pathway Molecules Are Hyperexpressed In The Bone Marrow Of Acute Promyelocytic Leukemia Patients Presenting Severe Coagulopathy

Priscila S Scheucher - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Prognostic Impact Of MLL5 transcript Levels On Outcome Of Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study

Antonio R Lucena-Araujo - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Tretinoin

Filters

7277 Abstracts